HIV, Immune Activation and Salt Sensitive Hypertension

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
HIV-1-infectionHypertension,Essential
Interventions
DIETARY_SUPPLEMENT

Dietary salt (Sodium chloride)

Dietary salt used was sodium chloride tablets (from the research consolidated midland corporation division, New York, USA) which participants crashed and put in their food and/or ingested. Each tablet weighed one (1) gram and contained 394 mg of sodium and 606 mg of chloride.

Trial Locations (1)

10101

Livingstone Central Hospital, Livingstone

All Listed Sponsors
collaborator

University of Zambia

OTHER

collaborator

Vanderbilt University Medical Center

OTHER

lead

Mulungushi University

OTHER

NCT04459741 - HIV, Immune Activation and Salt Sensitive Hypertension | Biotech Hunter | Biotech Hunter